AI assistant
Sending…
Lineage Cell Therapeutics Inc. — Director's Dealing 2012
Feb 9, 2012
6895_dirs_2012-02-09_833c0462-1694-4806-8c5e-964cb46d1198.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2011-12-31
Reporting Person: GREENBELT CORP /NY (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-01-12 | Common Shares, no par value | G | 2400 | — | Disposed | 1970505 | Direct |
Footnotes
F1: During January 2011, Greenbelt Corp. donated a total of 2,400 shares to certain charitable and non-profit organizations.
More from Lineage Cell Therapeutics Inc.
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Report Publication Announcement
2026
May 13
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Report Publication Announcement
2026
May 5
Earnings Release
2026
May 5
Investor Presentation
2026
May 4